Ning Gu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 23

Top Topics

Acute Myocardial Infarction

Ejection Fraction

Cardiovascular Disease

Top Venues

Cardiovascular diabetology

Sleep & breathing = Schlaf & Atmung

Disease markers

BMC complementary medicine and therapies

This page only lists publications with an associated author ORCID identifier.

Publications

Songyi Cheng, Jing Wu, Yinghao Pei, Huaqin Tong, Manlu Fan, Qian Xiang, Yuhan Ding, Liang Xie, Haowen Zhang, Weixin Sun, Xiaoxiao Zhang, Yongchun Zhu, Ning Gu
Guanxin V alleviates ventricular remodeling after acute myocardial infarction with circadian disruption by regulating mitochondrial dynamics. Sleep & breathing = Schlaf & Atmung 28 (2) (2023)
Songyi Cheng, Jing Wu, Yinghao Pei, Huaqin Tong, Manlu Fan, Qian Xiang, Yuhan Ding, Liang Xie, Haowen Zhang, Weixin Sun, Xiaoxiao Zhang, Yongchun Zhu, Ning Gu
Guanxin V alleviates ventricular remodeling after acute myocardial infarction with circadian disruption by regulating mitochondrial dynamics. Sleep & breathing = Schlaf & Atmung 28 (2) (2023)
Zhihuan You, Xiaotian Ye, Meihua Jiang, Ning Gu, Caihong Liang
lnc-MRGPRF-6:1 Promotes ox-LDL-Induced Macrophage Ferroptosis via Suppressing GPX4. Mediators of inflammation 2023 (2023)
Songyi Cheng, Jing Wu, Yinghao Pei, Huaqin Tong, Manlu Fan, Qian Xiang, Yuhan Ding, Liang Xie, Haowen Zhang, Weixin Sun, Xiaoxiao Zhang, Yongchun Zhu, Ning Gu
Guanxin V alleviates ventricular remodeling after acute myocardial infarction with circadian disruption by regulating mitochondrial dynamics. Sleep & breathing = Schlaf & Atmung (2023)
Bo Liang, Ning Gu
High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 100 (1) (2022)
Bo Liang, Rui Li, Peng Zhang, Ning Gu
Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism. Journal of cardiovascular translational research (2022)
Bo Liang, Yi Liang, Li-Zhi Zhao, Yu-Xiu Zhao, Ning Gu
Rivaroxaban for cancer-associated venous thromboembolism. Science progress 104 (2) (2022)
Bo Liang, Yi Liang, Ning Gu
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. BMC cardiovascular disorders 22 (1) (2022)
Bo Liang, Ning Gu
Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251. Diabetes care 45 (10) (2022)
Bo Liang, Yong-Chun Zhu, Jia Lu, Ning Gu
Effects of Traditional Chinese Medication-Based Bioactive Compounds on Cellular and Molecular Mechanisms of Oxidative Stress. Oxidative medicine and cellular longevity 2021 (2021)
Bo Liang, Ning Gu
Treatment strategies in patients with diabetes and three-vessel coronary disease: What should we choose? Cardiovascular diabetology 20 (1) (2021)
Xiaoxiao Zhang, Changle Shao, Songyi Cheng, Yao Zhu, Bo Liang, Ning Gu
Effect of Guanxin V in animal model of acute myocardial infarction. BMC complementary medicine and therapies 21 (1) (2021)
Bo Liang, Yi Liang, Rui Li, Ning Gu
Effect of renal denervation on long-term outcomes in patients with resistant hypertension. Cardiovascular diabetology 20 (1) (2021)
Jian-Guo Zhou, Bo Liang, Jian-Guo Liu, Su-Han Jin, Si-Si He, Benjamin Frey, Ning Gu, Sandra Rutzner, Markus Hecht, Hu Ma, Udo S Gaipl
Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells 10 (5) (2021)
Rong-Hua Yang, Bo Liang, Jie-Hua Li, Xiao-Bing Pi, Kai Yu, Shi-Jian Xiang, Ning Gu, Xiao-Dong Chen, Si-Tong Zhou
Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Journal of cellular and molecular medicine 25 (23) (2021)
Bo Liang, Yu-Xiu Zhao, Xiao-Xiao Zhang, Hui-Ling Liao, Ning Gu
Reappraisal on pharmacological and mechanical treatments of heart failure. Cardiovascular diabetology 19 (1) (2020)
Xin He, Bo Liang, Ning Gu
Th17/Treg Imbalance and Atherosclerosis. Disease markers 2020 (2020)
Bo Liang, Yu-Xiu Zhao, Ning Gu
Renal Denervation for Resistant Hypertension: Where Do We Stand? Current hypertension reports 22 (10) (2020)
Bo Liang, Xin He, Yu-Xiu Zhao, Xiao-Xiao Zhang, Ning Gu
Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases. BioMed research international 2020 (2020)
Bo Liang, Xiao-Xiao Zhang, Ning Gu
Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease. BMC complementary medicine and therapies 20 (1) (2020)
Bo Liang, Shuang-Yang Li, Hui-Zhi Gong, Ling-Xue Wang, Jia Lu, Yu-Xiu Zhao, Ning Gu
Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma. Disease markers 2020 (2020)
Bo Liang, Ning Gu
Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE. Cardiovascular diabetology 19 (1) (2020)
Bo Liang, Yu-Xiu Zhao, Ning Gu
Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions. Cardiovascular diabetology 19 (1) (2020)